MedTrace Logo

Salivary Glycated Albumin

NCT03235492 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2023-12-20

No results posted yet for this study

Summary

(1) to determine whether the ratio of glycated albumin and total albumin in saliva is equivalent to blood and (2) to investigate whether the non-invasive SmartAlbu portable salivary sensor is as accurate as standard tests that measure glycosylated hemoglobin (HbA1c).

Conditions

Interventions

DEVICE

SmartAlbu

Plan: 1. Consent an individual 2. Measure and record temperature, blood pressure, heart rate, height and weight 3. Obtain two samples of saliva for the SmartAlbu portable salivary sensor 4. Take a venous blood sample for HbA1c and 5. Glycated albumin 6. Obtain blood sample from a finger stick for point of care HbA1c device

Sponsors & Collaborators

  • University of Maryland, Baltimore

    lead OTHER

Principal Investigators

  • Stephen N Davis, MBBS · University of Maryland, Baltimore

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-08-24
Primary Completion
2023-12-05
Completion
2023-12-05

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03235492 on ClinicalTrials.gov